This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsMonte Rosa TherapeuticsMonte Rosa Therapeutics Funding Rounds, Valuation & Investors
Develops molecular glue degrader medicines for cancer, autoimmune, and inflammatory diseases51-200 Employees
Monte Rosa Therapeutics Funding
$300M
11 round
Monte Rosa Therapeutics is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $300M. Their most recent funding was raised on January 8, 2026.
Funding Rounds
S
$300000000